The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday ...

The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday.

The ketamine-derived drug was first approved in 2019 to be used in combination with antidepressants, and later for patients experiencing suicidal thoughts or actions. “Now that it is also ...

This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...

Spravato, which is derived from ketamine, is not a new drug—it first came on the market in 2019. The spray was previously approved as a companion treatment to an oral antidepressant, as well as ...

SINGAPORE – Ketamine, the controlled drug best known as a horse tranquilliser or party supplement, has in the last four years become a boon to scores of severely depressed patients in Singapore.

Recreational ketamine use has local researchers sounding the alarm. Dr. Philip Botkiss is the medical director of the West Coast Ketamine Center. He says he's seen a good response from patients ...

Celebrities like Matthew Perry, Chrissy Teigen and others have been open about using ketamine infusion therapy to help treat mental health conditions. According to the United States Drug ...

In interviews, Musk has mentioned using doctor-prescribed ketamine to alleviate periods of depression. He believes that managing his mental health is beneficial not only for his well-being but also ...

HCL Tech Shares: Stocks tumble over 9% after Q3 earnings (Image: Reuters) HCL Tech Share Price: HCL Technologies saw its shares take a sharp plunge on Tuesday January 14. The stock began trading ...